ITOS — iTeos Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for iTeos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	19.9	336	849	613	532
Net Total Receivables	5.33	0.325	12.1	2.44	6.5
Prepaid Expenses
Total Current Assets	26.1	340	875	628	551
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.34	1.35	7.4	6.77	10.7
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	30.7	345	885	755	668
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	13.2	15	304	42	40
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.1	21.4	332	91.7	92.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	15.7	323	553	663	575
Total Liabilities & Shareholders' Equity	30.7	345	885	755	668
Total Common Shares Outstanding